CN111150545A - Phase-change cooling support, preparation method thereof and phase-change cooling combined support - Google Patents

Phase-change cooling support, preparation method thereof and phase-change cooling combined support Download PDF

Info

Publication number
CN111150545A
CN111150545A CN202010001436.8A CN202010001436A CN111150545A CN 111150545 A CN111150545 A CN 111150545A CN 202010001436 A CN202010001436 A CN 202010001436A CN 111150545 A CN111150545 A CN 111150545A
Authority
CN
China
Prior art keywords
phase
change cooling
change
spiral shell
bracket
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010001436.8A
Other languages
Chinese (zh)
Inventor
张敬学
毛迎燕
王宁利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Tongren Hospital
Original Assignee
Beijing Tongren Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Tongren Hospital filed Critical Beijing Tongren Hospital
Priority to CN202010001436.8A priority Critical patent/CN111150545A/en
Publication of CN111150545A publication Critical patent/CN111150545A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00781Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y80/00Products made by additive manufacturing
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K5/00Heat-transfer, heat-exchange or heat-storage materials, e.g. refrigerants; Materials for the production of heat or cold by chemical reactions other than by combustion
    • C09K5/02Materials undergoing a change of physical state when used
    • C09K5/06Materials undergoing a change of physical state when used the change of state being from liquid to solid or vice versa
    • C09K5/066Cooling mixtures; De-icing compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00885Methods or devices for eye surgery using laser for treating a particular disease
    • A61F2009/00891Glaucoma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes

Abstract

The invention relates to the technical field of ophthalmic stents, in particular to a phase-change cooling stent and a preparation method and application thereof. The phase-change cooling support comprises a spiral shell with a hollow structure and a core material filled in the spiral shell, wherein the core material is a phase-change cooling material, and the spiral shell is a medical high polymer material; the outer diameter of the phase-change cooling bracket is adapted to the inner diameter of the Schlemm's tube. The invention takes the phase-change cooling material as a core layer component, and the phase-change cooling material can automatically absorb or release heat energy to the environment by utilizing the phase state or the structural change of the phase-change cooling material, thereby achieving the purpose of regulating and controlling the environment temperature.

Description

Phase-change cooling support, preparation method thereof and phase-change cooling combined support
Technical Field
The invention relates to the technical field of ophthalmic supports, in particular to a phase-change cooling support, a preparation method thereof and a phase-change cooling combined support.
Background
Glaucoma is the first irreversible blinding eye disease in the world and is mainly classified into Primary closed angle Glaucoma (PACG) and Primary Open Angle Glaucoma (POAG). With the development of socioeconomic in China and the change of life style of people, POAG has become the most common irreversible high-blindness eye disease in China at present, and accounts for 70.4 percent of the total number of glaucoma patients. Increased intraocular pressure is considered to be an important factor in the onset of glaucoma and is the only factor that can be intervened at present, and increased resistance to drainage of aqueous humor is considered to be the main cause of increased intraocular pressure. While the anterior chamber angle of POAG is open, its increased intraocular pressure is primarily due to lesions of the trabecular meshwork cells, resulting in increased resistance of the aqueous humor drainage system.
Clinically current treatment regimens for glaucoma are primarily targeted at lowering intraocular pressure, including drugs and surgery. Drug therapy is usually the first choice, but currently available drug therapies almost require at least once daily use to be effective, which can have a number of serious side effects, including: congestive heart disease, tachypnea, hypertension, depression, kidney stones, aplastic anemia, and sexual dysfunction; drug compliance is also a major problem, and it is estimated that more than half of glaucoma patients do not follow their correct time dose, causing fluctuations in intraocular pressure, resulting in optic nerve damage and visual field defects. When the administration of the drug is insufficient to reduce the intraocular pressure, laser trabeculoplasty or trabeculectomy is usually performed, and such intervention may cause scarring of the scleral flap, closing the outflow tract of the artificially-made aqueous humor, thereby causing the intraocular pressure to rise again; at the same time, a pathway for bacteria on the surface of the eye and eyelids to enter the interior of the eye is also created, and an internal eye infection known as endophthalmitis, which often results in permanent and more severe loss of vision, can occur. Therefore, there is an urgent need for novel and effective therapeutic means for continuously lowering intraocular pressure.
Disclosure of Invention
The phase-change cooling bracket provided by the invention can absorb heat by utilizing the phase-change process of the phase-change cooling material, reduce the environmental temperature of trabecular meshwork tissues, prevent and relieve protein error folding of trabecular meshwork cells, can repeatedly act, continuously reduce intraocular pressure and slow down or block the pathological process of glaucoma.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides a phase-change cooling support which comprises a spiral shell with a hollow structure and a core material filled in the spiral shell, wherein the core material is a phase-change cooling material, and the spiral shell is a medical high polymer material; the outer diameter of the phase-change cooling bracket is adapted to the inner diameter of the Schlemm's tube.
Preferably, the length of the phase-change cooling support is 1-6 mm.
Preferably, the mass ratio of the spiral shell to the core material is (40-80): (20-60).
Preferably, the raw materials for preparing the phase-change cooling material comprise hydrogel, an organic phase-change material and a gelling agent.
Preferably, the mass ratio of the hydrogel to the organic phase change material to the gelling agent is (20-60): (30-80): (1-10).
Preferably, the organic phase change material comprises one or more of polyvinyl alcohol, isopropanol, glycerol and propylene glycol.
The invention also provides a preparation method of the phase change cooling bracket in the technical scheme, which comprises the following steps:
and (3) printing the phase-change cooling material serving as a core material and the medical high polymer material serving as a spiral shell by adopting a 3D printing technology to obtain the phase-change cooling support.
The invention also provides a phase-change cooling combined bracket, which is formed by combining a plurality of phase-change cooling brackets in the technical scheme or the phase-change cooling brackets prepared by the preparation method in the technical scheme; the combination mode is to connect the port of the phase change cooling bracket to the port.
Preferably, the spiral pitch between each phase change cooling support is 0.2-0.5 mm.
The invention provides a phase-change cooling support which comprises a spiral shell with a hollow structure and a core material filled in the spiral shell, wherein the core material is a phase-change cooling material, and the spiral shell is a medical high polymer material; the outer diameter of the phase-change cooling bracket is adapted to the inner diameter of the Schlemm's tube. The phase-change cooling material is used as a core material, and can automatically absorb heat energy to the environment by utilizing the phase-change cooling material according to the self phase state or structure change, so that the aim of regulating and controlling the environment temperature is fulfilled; the phase-change cooling material is coated and fixed in a bracket shape by using a medical high polymer material, is implanted into Schlemm's canal (Schlemm), can ensure the cooling effect of the phase-change cooling material, and is suitable for treating glaucoma. The phase change cooling support provided by the invention is simple in structure, low in manufacturing cost and suitable for popularization and application.
Drawings
Fig. 1 is a schematic view of a phase change cooling stent prepared in embodiment 1 of the present invention;
FIG. 2 is a schematic diagram of a phase change process of the phase change temperature reducing material.
Detailed Description
The invention provides a phase-change cooling support which comprises a spiral shell with a hollow structure and a core material filled in the spiral shell, wherein the core material is a phase-change cooling material, and the spiral shell is a medical high polymer material; the outer diameter of the phase-change cooling bracket is adapted to the inner diameter of the Schlemm's tube.
The phase change cooling support provided by the invention comprises a spiral shell with a hollow structure, wherein the spiral shell is made of a medical high polymer material, and hydrogel is preferable. In the present invention, the thickness of the hydrogel is preferably 200 to 500. mu.m.
The phase-change cooling support provided by the invention comprises a core material filled in the spiral shell, wherein the core material is a phase-change cooling material, the preparation raw materials of the phase-change cooling material preferably comprise hydrogel, an organic phase-change material and a gelling agent, and the mass ratio of the hydrogel to the organic phase-change material to the gelling agent is preferably (20-60): (30-80): (1-10). In the present invention, the thickness of the hydrogel is preferably 200 to 500. mu.m. In the invention, the hydrogel is used as a matrix of the phase-change cooling material to coat the phase-change material.
In the invention, the phase change temperature of the organic phase change material is preferably 30-34 ℃, and more preferably 31-33 ℃; the organic phase change material preferably comprises one or more of polyvinyl alcohol, isopropanol, glycerol and propylene glycol. In the invention, the organic phase-change material takes away local micro-environment heat through a phase-change process, reduces the local temperature of trabecular meshwork tissues (reaching 32 +/-2 ℃), reverses or blocks protein misfolding and accumulation of trabecular meshwork cells by utilizing a low-temperature environment, improves the blocked state of outflow of aqueous humor, can act repeatedly, and realizes continuous intraocular pressure reduction through one-time intervention.
In the invention, the specific composition of the gelling agent is preferably sodium alginate or borax. The invention enhances the adhesion between the organic phase-change material and the hydrogel through the gelling agent, and improves the stability and the durability of the phase-change cooling effect.
In the present invention, the preparation method of the phase-change cooling material preferably includes: and mechanically blending the hydrogel, the phase-change material and the gelling agent to obtain the phase-change cooling material. In the invention, the mechanical blending mode is preferably stirring, the stirring temperature is 30-80 ℃, and the stirring time is preferably 1-5 h.
In the invention, the phase-change cooling bracket is in the shape of a spiral bracket, as shown in figure 1. In the invention, the outer diameter of the phase-change cooling bracket is consistent with the inner diameter of the Schlemm's tube, particularly preferably 150-250 μm, and the length of the phase-change cooling bracket is preferably 1-6 mm.
The invention provides a preparation method of the phase change cooling bracket in the technical scheme, which comprises the following steps: and (3) printing the phase-change cooling material serving as a core material and the medical high polymer material serving as a spiral shell skin material by adopting a 3D printing technology to obtain the phase-change cooling support. The preparation method provided by the invention is simple and convenient, has high precision and can meet medical requirements.
The invention also provides a phase-change cooling combined bracket, which is formed by combining a plurality of phase-change cooling brackets in the technical scheme or the phase-change cooling brackets prepared by the preparation method in the technical scheme; the combination mode is that the ports of the phase-change cooling support are connected with the ports, and preferably the phase-change cooling support is connected in series. In the present invention, the joining is preferably performed by using a suture. In the invention, the pitch between each phase change cooling bracket is 0.2-0.5 mm. In a specific embodiment of the invention, the phase-change cooling combined bracket is formed by connecting 4-6 phase-change cooling brackets in series.
In the specific use process of the invention, the conventional eye surgery disinfection is preferably carried out firstly, the scleral flap is manufactured, and the phase-change cooling stent or the phase-change cooling combined stent is implanted into Schlemm's canal of a patient.
The invention adopts low-temperature physical therapy, has no side effect of drugs, avoids infection risk caused by an aqueous humor outflow channel manufactured by trabecular surgery, and more importantly, the stent therapy provided by the invention only needs one intervention, can achieve the aims of continuously reducing intraocular pressure, preventing and relieving abnormal protein accumulation of primary open-angle glaucoma trabecular meshwork tissue, and slowing down the damage loss of pathological trabecular cells and the pathological process of glaucoma.
The technical solution of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. It is to be understood that the described embodiments are merely exemplary of the invention, and not restrictive of the full scope of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
Mixing 1g of hydrogel, 0.5g of polyvinyl alcohol and 0.1g of sodium alginate, heating to 50 ℃ under uniform stirring, and stirring for 2 hours to obtain a phase-change cooling material;
and (3) placing the phase-change cooling material serving as a core material and 2g of medical pure water gel serving as a spiral shell material in a 3D printer, and obtaining the phase-change cooling support by adopting a 3D printing technology.
The schematic diagram of the obtained phase-change cooling stent is shown in fig. 1, the phase-change cooling stent is in the shape of a spiral stent, the length of the phase-change cooling stent is 3mm, the outer diameter of the phase-change cooling stent is 200 mu m, and when the phase-change cooling stent is used, a single stent can be implanted for use or a plurality of stents can be implanted for use in a combined manner according to the disease progression stage or the lesion degree in a grading. When a plurality of stents are used in a combined way, a plurality of phase-change cooling stents are connected in series through sutures to obtain a phase-change cooling combined stent, the pitch between the single phase-change cooling stents is 0.3mm, and then the combined stent is implanted into Schlemm's canal of a patient; the phase change process (as shown in figure 2) of the phase change composite material brings away local microenvironment heat, reduces local temperature of trabecular meshwork tissues, reverses or blocks protein misfolding and accumulation of trabecular meshwork cells by utilizing a low-temperature environment, improves the blocked state of outflow of aqueous humor, can repeatedly act, can continuously reduce intraocular pressure through one-time intervention, prevents and relieves abnormal protein accumulation of primary open-angle glaucoma trabecular meshwork tissues, and slows down damage loss of pathological changes of the trabecular meshwork cells and pathological processes of glaucoma.
Example 2
Mixing 1.2g of hydrogel, 0.6g of isopropanol and 0.2g of sodium alginate, heating to 60 ℃ under uniform stirring, and stirring for 1h to obtain a phase-change cooling material;
and (3) placing the phase-change cooling material serving as a core material and 3g of medical pure water gel serving as a spiral shell material in a 3D printer, and obtaining the phase-change cooling support by adopting a 3D printing technology.
Example 3
Mixing 1.5g of hydrogel, 0.8g of glycerol and 0.1g of borax, heating to 40 ℃ under uniform stirring, and stirring for 3 hours to obtain a phase-change cooling material;
and (3) placing the phase-change cooling material serving as a core material and 2.5g of medical pure water gel serving as a spiral shell material in a 3D printer, and obtaining the phase-change cooling support by adopting a 3D printing technology.
Example 4
Mixing 1g of hydrogel, 0.8g of propylene glycol and 0.2g of sodium alginate, heating to 70 ℃ under uniform stirring, and stirring for 0.5h to obtain a phase-change cooling material;
and (3) placing the phase-change cooling material serving as a core material and 4g of medical pure water gel serving as a spiral shell material in a 3D printer, and obtaining the phase-change cooling support by adopting a 3D printing technology.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.

Claims (9)

1. The phase-change cooling support is characterized by comprising a spiral shell with a hollow structure and a core material filled in the spiral shell, wherein the core material is a phase-change cooling material, and the spiral shell is a medical high polymer material; the outer diameter of the phase-change cooling bracket is adapted to the inner diameter of the Schlemm's tube.
2. The phase-change cooling bracket according to claim 1, wherein the length of the phase-change cooling bracket is 1-6 mm.
3. The phase change cooling support according to claim 1, wherein the mass ratio of the spiral shell to the core material is (40-80): (20-60).
4. The phase-change cooling bracket according to claim 1, wherein the phase-change cooling material is prepared from raw materials including hydrogel, organic phase-change material and gelling agent.
5. The phase-change cooling bracket according to claim 4, wherein the mass ratio of the hydrogel to the organic phase-change material to the gelling agent is (20-60): (30-80): (1-10).
6. The phase-change cooling bracket according to claim 4 or 5, wherein the organic phase-change material comprises one or more of polyvinyl alcohol, isopropanol, glycerol and propylene glycol.
7. The preparation method of the phase-change cooling bracket according to any one of claims 1 to 6, which is characterized by comprising the following steps:
and (3) printing the phase-change cooling material serving as a core material and the medical high polymer material serving as a spiral shell by adopting a 3D printing technology to obtain the phase-change cooling support.
8. A phase-change cooling combined bracket is characterized by being formed by combining a plurality of phase-change cooling brackets according to any one of claims 1 to 6 or prepared by the preparation method according to claim 7; the combination mode is to connect the port of the phase change cooling bracket to the port.
9. The phase-change cooling combined bracket according to claim 8, wherein the spiral pitch between each phase-change cooling bracket is 0.2-0.5 mm.
CN202010001436.8A 2020-01-02 2020-01-02 Phase-change cooling support, preparation method thereof and phase-change cooling combined support Pending CN111150545A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010001436.8A CN111150545A (en) 2020-01-02 2020-01-02 Phase-change cooling support, preparation method thereof and phase-change cooling combined support

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010001436.8A CN111150545A (en) 2020-01-02 2020-01-02 Phase-change cooling support, preparation method thereof and phase-change cooling combined support

Publications (1)

Publication Number Publication Date
CN111150545A true CN111150545A (en) 2020-05-15

Family

ID=70561025

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010001436.8A Pending CN111150545A (en) 2020-01-02 2020-01-02 Phase-change cooling support, preparation method thereof and phase-change cooling combined support

Country Status (1)

Country Link
CN (1) CN111150545A (en)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1377706A (en) * 2002-04-22 2002-11-06 沈阳药科大学 Ocular in-situ gel preparatino with proper phase conversion temperature
CN1688269A (en) * 2002-07-11 2005-10-26 生命恢复系统Hd责任有限公司 Apparatus for altering the body temperature of a patient
CN101405557A (en) * 2006-01-19 2009-04-08 摩丁制造公司 Flat tube, flat tube heat exchanger, and method of manufacturing same
CN102917674A (en) * 2010-01-08 2013-02-06 康尔福盛2200公司 Methods and apparatus for enhancing vascular access in an appendage to enhance therapeutic and interventional procedures
CN104127279A (en) * 2014-08-06 2014-11-05 陈蕾 Multifunctional film capable of adjusting temperature automatically and application of multifunctional film
CN104825270A (en) * 2008-02-18 2015-08-12 马缇医疗股份有限公司 Lacrimal implants and related methods
WO2016033374A1 (en) * 2014-08-27 2016-03-03 Tva Medical, Inc. Cryolipopysis devices and methods therefor
EP2370143B1 (en) * 2008-12-31 2017-08-02 KCI Licensing, Inc. Systems for providing fluid flow to tissues
CN207186682U (en) * 2018-01-15 2018-04-06 国创汇能(武汉)医学工程有限公司 New hemorrhoid cryotherapeutic apparatus
CN108601725A (en) * 2015-11-25 2018-09-28 因赛普特有限责任公司 The drug delivery device and method that shape changes
CN208481567U (en) * 2017-09-14 2019-02-12 国创汇能(武汉)医学工程有限公司 Novel icing eyeshade
CN109937025A (en) * 2016-04-20 2019-06-25 多斯医学公司 The delivery apparatus of biological absorbable ocular drug
CN109966559A (en) * 2017-12-28 2019-07-05 北京莱顿生物材料有限公司 A kind of medical implant and preparation method thereof
CN110087571A (en) * 2016-12-19 2019-08-02 波士顿科学医学有限公司 With the cooling open flushing ablation catheter of proximal end insertion piece

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1377706A (en) * 2002-04-22 2002-11-06 沈阳药科大学 Ocular in-situ gel preparatino with proper phase conversion temperature
CN1688269A (en) * 2002-07-11 2005-10-26 生命恢复系统Hd责任有限公司 Apparatus for altering the body temperature of a patient
CN101405557A (en) * 2006-01-19 2009-04-08 摩丁制造公司 Flat tube, flat tube heat exchanger, and method of manufacturing same
CN104825270A (en) * 2008-02-18 2015-08-12 马缇医疗股份有限公司 Lacrimal implants and related methods
EP2370143B1 (en) * 2008-12-31 2017-08-02 KCI Licensing, Inc. Systems for providing fluid flow to tissues
CN102917674A (en) * 2010-01-08 2013-02-06 康尔福盛2200公司 Methods and apparatus for enhancing vascular access in an appendage to enhance therapeutic and interventional procedures
CN104127279A (en) * 2014-08-06 2014-11-05 陈蕾 Multifunctional film capable of adjusting temperature automatically and application of multifunctional film
WO2016033374A1 (en) * 2014-08-27 2016-03-03 Tva Medical, Inc. Cryolipopysis devices and methods therefor
CN108601725A (en) * 2015-11-25 2018-09-28 因赛普特有限责任公司 The drug delivery device and method that shape changes
CN109937025A (en) * 2016-04-20 2019-06-25 多斯医学公司 The delivery apparatus of biological absorbable ocular drug
CN110087571A (en) * 2016-12-19 2019-08-02 波士顿科学医学有限公司 With the cooling open flushing ablation catheter of proximal end insertion piece
CN208481567U (en) * 2017-09-14 2019-02-12 国创汇能(武汉)医学工程有限公司 Novel icing eyeshade
CN109966559A (en) * 2017-12-28 2019-07-05 北京莱顿生物材料有限公司 A kind of medical implant and preparation method thereof
CN207186682U (en) * 2018-01-15 2018-04-06 国创汇能(武汉)医学工程有限公司 New hemorrhoid cryotherapeutic apparatus

Similar Documents

Publication Publication Date Title
US6533768B1 (en) Device for glaucoma treatment and methods thereof
RU2398566C2 (en) New use of viscoelastic composition
US20040210185A1 (en) Glaucoma implant kit
AU2001245698A1 (en) Device for glaucoma treatment and methods thereof
CN105997341B (en) A kind of preparation and its application method of the interior drainage substitution biomimetic scaffolds of glaucoma
US9339514B2 (en) Method for treating glaucoma
US8715266B2 (en) Glaucoma surgery
CN103190983A (en) Aqueous humor drainage implant
US10278920B1 (en) Drug delivery implant and a method using the same
CN101386203B (en) Manufacturing method of foldable artificial glass and die thereof
CN201029958Y (en) Non-penetrating integrated artificial cornea
CN111150545A (en) Phase-change cooling support, preparation method thereof and phase-change cooling combined support
CN110037854B (en) Glaucoma aqueous humor drainage device
Chan et al. New devices in glaucoma
CN111772919A (en) Drainage device for glaucoma valve filtering bulb part
CN211095211U (en) Schlemm's canal low-temperature support for continuously reducing intraocular pressure
CN114129889B (en) Annular microneedle for ophthalmology
CN110314252A (en) Collagen Implant is preparing the purposes in operation for glaucoma auxiliary reconstruction
Pourjavan et al. STARflo TM: A Suprachoroidal Drainage Implant Made from STAR® Biomaterial
CN110639066B (en) Degradable lacrimal duct suppository and preparation method and application thereof
Yuen et al. Combined phacoemulsification and nonpenetrating deep sclerectomy in the treatment of chronic angle-closure glaucoma with cataract
Wu et al. Efficacy and safety of biodegradable collagen-glycosaminoglycan polymer as a material for scleral buckling
Zhang et al. Use of 5-fluorouracil-soaked bioamniotic membranes in trabeculectomy for primary open-angle glaucoma: a retrospective analysis
RU2203007C1 (en) Method for treating the cases of neovascular glaucoma
CN218792739U (en) Aqueous humor drainage device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200515